Received: 11 December 2017
Accepted: 13 February 2018
First Online: 5 March 2018
Ethics approval and consent to participate
: Prof Fary Khan was the authorised prescriber of CN-NINM approved by the Therapeutic Goods Administration (TGA) of Australia and the Melbourne Health Human Research Ethics Committee.
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.